Dr. Salah-Uddin Ahmed's lab at Washington State University focuses on understanding the role of a protein called TAK1 in rheumatoid arthritis (RA). They study how TAK1 contributes to the inflammatory and invasive behaviors of synovial fibroblasts, which play a key role in RA pathology. The lab aims to develop targeted therapies using TAK1 inhibitors to improve treatment outcomes for patients suffering from this chronic disease.